Salvato in:
Dettagli Bibliografici
Autori principali: Cotton, Matthew W., Goriely, Alain, Klenerman, David, Meisl, Georg
Natura: Preprint
Pubblicazione: 2025
Soggetti:
Accesso online:https://arxiv.org/abs/2511.18893
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866908671462604800
author Cotton, Matthew W.
Goriely, Alain
Klenerman, David
Meisl, Georg
author_facet Cotton, Matthew W.
Goriely, Alain
Klenerman, David
Meisl, Georg
contents Neurodegenerative diseases are driven by the accumulation of protein aggregates in the brain of affected individuals. The aggregation behaviour in vitro is well understood and driven by the equilibration of a super-saturated protein solution to its aggregated equilibrium state. However, the situation is altered fundamentally in living systems where active processes consume energy to remove aggregates. It remains unclear how and why cells transition from a state with predominantly monomeric protein, which is stable over decades, to one dominated by aggregates. Here, we develop a simple but universal theoretical framework to describe cellular systems that include both aggregate formation and removal. Using a two-dimensional phase-plane representation, we show that the interplay of aggregate formation and removal generates cell-level bistability, with a bifurcation structure that explains both the emergence of disease and the effects of therapeutic interventions. We explore a wide range of aggregate formation and removal mechanisms and show that phenomena such as seeding arise robustly when a minimal set of requirements on the mechanism are satisfied. By connecting in vitro aggregation mechanisms to changes in cell state, our framework provides a general conceptual link between molecular-level therapeutic interventions and their impact on disease progression.
format Preprint
id arxiv_https___arxiv_org_abs_2511_18893
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle A universal phase-plane model for in vivo protein aggregation
Cotton, Matthew W.
Goriely, Alain
Klenerman, David
Meisl, Georg
Biomolecules
Neurodegenerative diseases are driven by the accumulation of protein aggregates in the brain of affected individuals. The aggregation behaviour in vitro is well understood and driven by the equilibration of a super-saturated protein solution to its aggregated equilibrium state. However, the situation is altered fundamentally in living systems where active processes consume energy to remove aggregates. It remains unclear how and why cells transition from a state with predominantly monomeric protein, which is stable over decades, to one dominated by aggregates. Here, we develop a simple but universal theoretical framework to describe cellular systems that include both aggregate formation and removal. Using a two-dimensional phase-plane representation, we show that the interplay of aggregate formation and removal generates cell-level bistability, with a bifurcation structure that explains both the emergence of disease and the effects of therapeutic interventions. We explore a wide range of aggregate formation and removal mechanisms and show that phenomena such as seeding arise robustly when a minimal set of requirements on the mechanism are satisfied. By connecting in vitro aggregation mechanisms to changes in cell state, our framework provides a general conceptual link between molecular-level therapeutic interventions and their impact on disease progression.
title A universal phase-plane model for in vivo protein aggregation
topic Biomolecules
url https://arxiv.org/abs/2511.18893